• 1. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 2. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 3. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
• 4. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 5. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Piperidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines
• Solvents and Organic Chemicals Organic Compounds Alcohol/Ether

Introduction to 2-(Piperidin-4-yl)propan-2-ol (CAS No: 22990-34-7)

2-(Piperidin-4-yl)propan-2-ol, identified by its Chemical Abstracts Service (CAS) number 22990-34-7, is a significant compound in the field of pharmaceutical chemistry and drug discovery. This molecule, featuring a piperidine moiety linked to a secondary alcohol functional group, has garnered attention due to its structural versatility and potential biological activity. The piperidine ring is a common pharmacophore in medicinal chemistry, known for its ability to enhance solubility, improve metabolic stability, and modulate receptor interactions. The alcohol functionality further contributes to the compound's reactivity and potential for further derivatization, making it a valuable intermediate in synthetic chemistry.

The structural features of 2-(Piperidin-4-yl)propan-2-ol position it as a promising candidate for various applications, particularly in the development of small-molecule drugs targeting neurological and cardiovascular diseases. Recent advancements in computational chemistry and high-throughput screening have highlighted the compound's potential as a scaffold for novel therapeutic agents. The piperidine ring's presence is particularly noteworthy, as it is frequently incorporated into drugs that require optimal pharmacokinetic properties. For instance, molecules containing this moiety have shown promise in treating conditions such as schizophrenia and depression by interacting with central nervous system receptors.

In the context of modern drug discovery, the synthesis and optimization of 2-(Piperidin-4-yl)propan-2-ol have been refined through innovative methodologies. Researchers have employed catalytic asymmetric hydrogenation and transition-metal-catalyzed reactions to achieve high yields and enantioselectivity, which are critical for pharmaceutical applications. These techniques not only improve the efficiency of producing the compound but also reduce the environmental impact of its synthesis. The development of green chemistry principles has further driven the adoption of sustainable practices in the preparation of 2-(Piperidin-4-yl)propan-2-ol, ensuring that its production aligns with global efforts to minimize chemical waste and energy consumption.

The biological activity of 2-(Piperidin-4-yl)propan-2-ol has been explored in several preclinical studies. Its ability to modulate enzyme activity and receptor binding has led to investigations into its potential as an antihypertensive agent. Additionally, preliminary data suggest that derivatives of this compound may exhibit anti-inflammatory properties, making it relevant for therapeutic strategies targeting chronic inflammatory diseases. The alcohol group in the molecule provides a site for further functionalization, allowing chemists to design analogs with enhanced potency or selectivity. This flexibility underscores the compound's importance as a building block in medicinal chemistry.

Recent research has also delved into the pharmacokinetic profile of 2-(Piperidin-4-yl)propan-2-ol using advanced modeling techniques. These studies have revealed insights into how the compound is metabolized and eliminated in vivo, providing critical data for optimizing its therapeutic use. Understanding these processes is essential for designing clinical trials that accurately assess the drug's efficacy and safety. The integration of machine learning algorithms has further accelerated these studies by predicting metabolic pathways and identifying potential liabilities early in the drug development process.

The industrial application of 2-(Piperidin-4-yl)propan-2-ol extends beyond academic research. Pharmaceutical companies are increasingly interested in licensing or synthesizing this compound for proprietary drug candidates. Its structural features make it a versatile intermediate for producing novel therapeutics across multiple therapeutic areas. The demand for high-quality starting materials like 2-(Piperidin-4-yl)propan-2-ol has driven advancements in synthetic methodologies, ensuring that manufacturers can meet industry standards for purity and yield.

In conclusion, 2-(Piperidin-4-yl)propan-2-ol (CAS No: 22990-34-7) represents a significant advancement in pharmaceutical chemistry. Its unique structural features, combined with its potential biological activity, make it a valuable asset in drug discovery efforts. As research continues to uncover new applications and optimize synthetic routes, this compound is poised to play an increasingly important role in the development of next-generation therapeutics. The ongoing integration of innovative technologies and sustainable practices ensures that its production remains efficient, cost-effective, and environmentally responsible.

• 1374568-02-1(4-cyclobutyl-4-Piperidinol)
• 949100-21-4(1-(piperidin-4-yl)cyclopentan-1-ol)
• 915921-27-6(3-methyl-1-piperidin-4-ylbutan-1-ol)
• 70724-77-5(2-Methyl-1-(piperidin-4-yl)propan-2-ol)
• 1358782-67-8(1-(Piperidin-4-yl)cyclopropan-1-ol)
• 6457-48-3(1-(piperidin-4-yl)ethan-1-ol)
• 273378-21-5(4-cyclohexylpiperidin-4-ol)
• 915919-67-4(2-methyl-1-piperidin-4-ylpropan-1-ol)
• 252723-21-0(2-piperidin-3-ylpropan-2-ol)
• 24152-48-5(1-piperidin-4-ylpropan-1-ol)